TNFerade™ Biologic Plus Radiation for Metastatic Melanoma

Summary

Phase II, open label study in which patients with metastatic melanoma (stage III or IV) who have cancer which is not considered curable by surgery will receive intratumoral injections of TNFerade™ plus radiation as a 4-week treatment, followed by a 3 year follow-up period.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications